Allarity Therapeutics Files 8-K Current Report
Ticker: ALLR · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1860657
Sentiment: neutral
Topics: 8-k, filing, corporate-update
Related Tickers: ALLR
TL;DR
ALLARITY THERAPEUTICS (ALLR) FILED AN 8-K ON 6/30/25 FOR AN EVENT ON 6/27/25. STANDARD FILING.
AI Summary
Allarity Therapeutics, Inc. filed an 8-K on June 30, 2025, reporting an event that occurred on June 27, 2025. The filing indicates the company is incorporated in Delaware and its principal executive offices are located at 123 E Tarpon Ave, Tarpon Springs, FL 34689. The report is a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing signifies a routine update to the SEC, providing official information about the company's operational status and corporate details.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for a current report, not indicating any specific negative or positive material events.
Key Players & Entities
- Allarity Therapeutics, Inc. (company) — Registrant
- June 27, 2025 (date) — Earliest event reported
- June 30, 2025 (date) — Date of report
- 123 E Tarpon Ave, Tarpon Springs, FL 34689 (location) — Principal executive offices
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the purpose of this Form 8-K filing?
This Form 8-K is a current report filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934, indicating a reportable event has occurred.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 27, 2025.
What is the filing date of this 8-K?
This 8-K was filed on June 30, 2025.
Where are Allarity Therapeutics, Inc.'s principal executive offices located?
The principal executive offices of Allarity Therapeutics, Inc. are located at 123 E Tarpon Ave, Tarpon Springs, FL 34689.
In which state is Allarity Therapeutics, Inc. incorporated?
Allarity Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding Allarity Therapeutics, Inc. (ALLR).